Harvard Bioscience (HBIO) Revenue Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.47 Bn | 121.26 Bn | 1.96 Bn | 18.54% |
| 2 | Becton Dickinson | 44.86 Bn | 44.04 Bn | 2.15 Bn | 5.22% |
| 3 | Medline | 32.88 Bn | 30.65 Bn | 1.84 Bn | 10.66% |
| 4 | Alcon | 32.87 Bn | 31.21 Bn | 1.53 Bn | - |
| 5 | Resmed | 29.46 Bn | 27.80 Bn | 890.98 Mn | 10.81% |
| 6 | West Pharmaceutical Services | 23.43 Bn | 22.99 Bn | 329.20 Mn | 13.80% |
| 7 | Solventum | 14.07 Bn | 13.51 Bn | 1.10 Bn | -3.04% |
| 8 | Cooper Companies | 13.78 Bn | 13.64 Bn | 735.40 Mn | 7.90% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 6.21% |
| 10 | Harvard Bioscience | 27.26 Mn | 20.16 Mn | 12.24 Mn | -4.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.68% |
| Dec 31, 2025 | -3.34% |
| Sep 30, 2025 | -6.28% |
| Jun 30, 2025 | -11.46% |
| Mar 31, 2025 | -11.17% |
| Dec 31, 2024 | -12.78% |
| Sep 30, 2024 | -13.38% |
| Jun 30, 2024 | -19.69% |
| Mar 31, 2024 | -18.23% |
| Dec 31, 2023 | -0.96% |
| Sep 30, 2023 | -5.79% |
| Jun 30, 2023 | -1.54% |
| Mar 31, 2023 | 4.16% |
| Dec 31, 2022 | -14.00% |
| Sep 30, 2022 | -9.24% |
| Jun 30, 2022 | 0.04% |
| Mar 31, 2022 | 6.63% |
| Dec 31, 2021 | 6.68% |
| Sep 30, 2021 | 23.41% |
| Jun 30, 2021 | 25.27% |